Affiliate disclosure: The RX Index earns a commission when you sign up with some of the providers mentioned on this page. It does not affect what you pay, and it never determines our rankings or which providers we cover. Read the full disclosure.

Last verified: May 5, 2026 · Sources: Eli Lilly,¹ FDA,² Reuters³ · Our methodology

Availability Tracker · Updated May 5, 2026

Orforglipron Availability: Foundayo Is FDA-Approved and Available in the U.S.

Published: March 31, 2026 · Last updated: May 5, 2026 · Last reviewed: May 5, 2026

Yes — orforglipron (brand name Foundayo) was FDA-approved on April 1, 2026 for chronic weight management in adults. Eli Lilly launched it through LillyDirect starting at $149/month for the lowest dose, and began shipping within days of approval. It is also covered through the Medicare GLP-1 Bridge at $50/month for eligible beneficiaries.

If you've been searching for orforglipron availability, here's the full picture — current status, the timeline backed by sources you can check yourself, the pricing paths Lilly has publicly disclosed, how to avoid scams, and an honest breakdown of whether waiting makes sense for your situation. We verified every major claim on this page and linked the sources below.

Orforglipron Availability Snapshot

Every row verified May 5, 2026. We update within 24 hours of any FDA action or Lilly announcement.

Is Orforglipron Available Right Now?

Yes — with a prescription. Foundayo (orforglipron) was FDA-approved on April 1, 2026 and shipped through LillyDirect starting April 6, 2026, with broader retail and telehealth availability beginning April 9, 2026.¹²

You will need a valid prescription from a licensed clinician. LillyDirect is the manufacturer's direct-to-patient self-pay channel; CVS, Walgreens, and other licensed pharmacies fill it like any other GLP-1; Ro and similar telehealth services prescribe and coordinate fulfillment. Any site selling “orforglipron” without a prescription workflow is not the FDA-approved Foundayo pathway — see the scam warning below.

Foundayo is now available nationwide through licensed prescription channels. If you're comparing it against options you may already be on, the decision section below breaks down when Foundayo is the right fit and when an injectable GLP-1 may still be the stronger choice for your goals.

When Will Orforglipron Be Available?

The answer has gotten much sharper in the last few months.

Key Timeline Milestones

Historical note: Reuters reported April 10, 2026 as the target action date in the weeks before approval. The FDA ultimately approved Foundayo (orforglipron) nine days earlier on April 1, 2026 via the CNPV expedited pathway, following four positive Phase 3 trials and Lilly's pre-launch manufacturing build-out.

Is April 10 the Official FDA Decision Date?

This is a question we still get, so the short answer:

No — the actual FDA approval date was April 1, 2026. Reuters had reported, citing internal regulatory documents, that April 10 was the target action date.³ Lilly's pre-approval public language was “Q2 2026.”¹ The FDA approved Foundayo nine days ahead of the Reuters-reported target — a faster-than-expected outcome under the CNPV expedited pathway.¹²

How Much Will Orforglipron Cost?

Price is the second-biggest question after “when” — and the news is better than most people expect. In November 2025, Eli Lilly announced a government agreement to expand access to its obesity medicines. The deal included specific pricing commitments for orforglipron if it receives FDA approval.⁵

Verified Orforglipron Pricing Paths

Note: The Lilly government agreement specifically states that the commercial channel is not included in these pricing obligations.⁵ Commercial copay estimates from other sources are speculative until orforglipron is approved and on formulary.

Why This Pricing Is Noteworthy

Orforglipron is a small-molecule drug, not a peptide. That makes it fundamentally cheaper to manufacture than injectable GLP-1s — no cold storage, no complex biologic production, no injection devices. Lilly's CEO has said publicly that the lower manufacturing complexity could translate to better affordability.

Here's how orforglipron's disclosed pricing compares to what's available today:

Should You Wait for Orforglipron or Start an Oral GLP-1 Now?

As of May 2026 this is no longer a wait-vs-start question — both drugs are available. The Wegovy pill (oral semaglutide) was approved in December 2025 and Foundayo (orforglipron) was approved on April 1, 2026.⁷ The choice is now between two FDA-approved oral GLP-1s with different efficacy, dosing, and pricing profiles.

Decision Framework

If You Don't Want to Wait: The Current Path

You can read our full Orforglipron vs. Wegovy Pill comparison for the deep breakdown. But here's the short version.

The Wegovy Pill — Available Today

The Wegovy pill was FDA-approved in December 2025 and is available at pharmacies nationwide.⁷ The highest-dose oral semaglutide has shown weight loss in the range of 14–17% in clinical trials — putting it in striking distance of the injectable versions.

The catch: You need to take it first thing in the morning on an empty stomach with a small amount of water, then wait 30 minutes before eating, drinking, or taking other medications.⁷ For some people, that's manageable. For others, it's a dealbreaker.

Current self-pay pricing: $149/month for 1.5mg and 4mg doses (through August 31, 2026). Higher doses (9mg, 25mg) are $299/month.⁷

Here's something worth knowing: Lilly's own ATTAIN-MAINTAIN trial data supports switching from injectable Wegovy or Zepbound to orforglipron while maintaining most of the weight loss you've already achieved.⁹ That means starting now and transitioning later isn't settling — it's a strategy backed by Phase 3 data. You don't have to choose one path forever.

Every month you spend deciding is a month of progress you could be making. Read our full Orforglipron vs. Wegovy Pill breakdown →

Why Everyone's Watching Orforglipron

What Do the Clinical Trial Results Show?

Here are the numbers. No spin.

How Does This Stack Up?

*Based on higher-dose clinical trial data for oral semaglutide.

Losing 12% of your body weight is meaningful — for someone starting at 250 lbs, that's 30 pounds. Where orforglipron wins is the convenience equation: daily pill, no fasting, no needles, no refrigeration.

What Are the Side Effects?

No honest availability page skips this. Here's what the trial data shows. In Phase 3 trials, Lilly says orforglipron's safety profile was consistent with the GLP-1 class, with gastrointestinal side effects most commonly reported.¹⁰ ¹¹ Final U.S. warning language will depend on the approved label.

Practical takeaway: The GI side effects are somewhat more frequent than oral semaglutide, but they typically improve during the dose titration period when you start low and increase gradually. If you've tolerated a GLP-1 before, you'll likely tolerate orforglipron. If you haven't, expect an adjustment period — it's normal with this entire drug class.

Is Orforglipron the Right GLP-1 for You?

How to Prepare for Orforglipron Launch Day

If you've decided to wait, here's a checklist that could save you weeks of frustration once the FDA acts.

Before the FDA decision (do this now):

1. 1Talk to your doctor. Ask if they'd be willing to prescribe orforglipron once available. Having that conversation now means you're not starting from scratch on launch day.
2. 2Check your insurance. Call member services and ask: “Do you cover GLP-1 medications for weight loss?” and “What’s your prior authorization process?” If they cover Mounjaro or Zepbound, orforglipron may eventually get similar treatment.
3. 3Get familiar with LillyDirect. It's expected to be the first access channel. Create an account so you're ready.
4. 4Document your health conditions. Prior authorization typically requires BMI documentation, weight-related comorbidities, and evidence that lifestyle interventions alone haven't been sufficient. Having recent labs ready speeds up the process.
5. 5Know your pricing path. $149–$399 self-pay via LillyDirect. $50/month for qualifying Medicare beneficiaries. Commercial insurance: TBD. Knowing your path before launch day eliminates one more point of friction.

After FDA approval (if it happens):

1. 6Contact your doctor immediately to request a prescription.
2. 7Check LillyDirect first — it's expected to be the fastest route.
3. 8If using insurance, expect a formulary delay. Self-pay through LillyDirect may be faster while insurance catches up.
4. 9Start at the lowest dose. Orforglipron uses dose titration — you start low and increase over weeks to minimize side effects.

Frequently Asked Questions

What Happens Next

You're not behind. You're right on time.